Improving Musculoskeletal Care Quality With a Web-Based Clinical Decision Support System in UK Primary Care: Mixed Methods Cluster-Randomized Controlled Trial.

title: "Web-Based Decision Support Cuts Suboptimal Musculoskeletal Care in UK Primary Care, But Engagement Was Limited"

description: "A cluster-randomized trial of the CrossCover clinical decision support system found large reductions in non-evidence-based MSK management when clinicians used it, but low overall uptake."

date: "2025"

category: "Research Update"

studyType: "Cluster-randomized controlled trial (mixed methods)"

TL;DR: In a 19-practice UK trial, a web-based clinical decision support system (CDSS) for musculoskeletal (MSK) consultations was associated with much lower rates of non-evidence-based management when it was actually used, but clinicians used it in fewer than 9% of eligible consultations. This is a health-services study, not a supplement or habit study, and the result is best read as evidence about primary care tooling.

What the study found

Musculoskeletal conditions account for roughly one in seven general practice consultations in the United Kingdom. National guidelines exist, yet care that departs from them remains common. This trial asked whether a digital decision support tool, CrossCover, could improve that care. The study was a mixed methods, cluster-randomized controlled trial run across 19 general practices between February and July 2024, with practices randomized 1:1 and stratified by list size. Intervention practices received training and access to the CDSS for three months.

The primary outcome was the proportion of patient records containing one or more of 12 predefined non-evidence-based management options, judged by blinded clinical reviewers. Reviewers examined 120 records (60 per arm). In the intervention arm, suboptimal management was counted only at consultations where the CDSS was used. Under this per-protocol framing, suboptimal care appeared in 3% (2/60) of CDSS-guided consultations versus 25% (15/60) of control consultations, with an adjusted odds ratio of 12.30 (95% CI 2.52 to 59.9; P=.002). The authors are explicit that this comparison conditions on use, and that the wide confidence interval reflects a small number of events.

The intention-to-treat picture is more modest and more important for judging real-world impact. Across 10,182 eligible adults with MSK conditions (4,268 intervention, 5,914 control), the CDSS was used in 365 patient cases, or 8.6%. The intervention increased self-management advice alone, and it was associated with more community referrals, fewer prescriptions, and reduced fit-note use. Because most eligible patients were never touched by the tool, the average effect across the whole practice population is far smaller than the per-protocol result suggests.

Safety and sustainability were also assessed. Safety concerns were logged in 6.6% (24/365) of uses, with no high-risk issues identified. Environmental and economic modeling estimated an 18% reduction in carbon emissions and 10% annual cost savings if the intervention were scaled, though these are model projections rather than measured outcomes. Semistructured interviews with 18 clinicians described favorable views of the CDSS's content and safety netting, alongside frustration with integration into existing workflows.

The authors conclude that when used, CrossCover significantly reduced suboptimal MSK management, but that overall engagement was limited. Outcome assessors were blinded, but clinicians were not, which is a recognized source of potential bias in trials of this kind. The mixed picture of strong per-protocol effects and weak uptake is the central finding: the tool appears to work when clinicians reach for it, but getting them to reach for it is the unsolved problem.

What this means for you

This study does not test any supplement or lifestyle habit, so there are no product or behavior recommendations to draw from it. Its relevance to readers is indirect:

If you are a clinician or practice manager, the study suggests that decision support tools can change care when they are used, but that adoption depends heavily on workflow fit and implementation support. A tool that is not integrated into the consultation is unlikely to change outcomes at scale.

If you are a patient with an MSK condition, the most useful takeaway is that national guidelines emphasize self-management and appropriate referral, and that care which departs from them is common. Asking your clinician how their recommendation aligns with current guidance is a reasonable question.

For evidence-literate readers, note the difference between per-protocol and intention-to-treat results. The large odds ratio describes consultations where the tool was used. The population-level effect is much smaller because the tool was used in under 9% of eligible cases.

Study details

Item	Detail
Study type	Mixed methods cluster-randomized controlled trial
Setting	19 general practices, United Kingdom
Dates	February to July 2024
Participants	10,182 eligible adults with MSK conditions (4,268 intervention; 5,914 control)
Intervention	CrossCover web-based clinical decision support system, 3 months
Primary outcome	Proportion of records with non-evidence-based management (blinded review of 120 records)
Key result (per-protocol)	3% vs 25% suboptimal care; aOR 12.30 (95% CI 2.52 to 59.9; P=.002)
Key result (intention-to-treat)	CDSS used in 8.6% of cases; increased self-management advice
Safety	Concerns logged in 6.6% of uses; no high-risk issues identified
Qualitative component	18 clinician interviews
Journal	Journal of Medical Internet Research
Sample size reported	18 (clinician interviews)

Sources

1. Cluster-randomized controlled trial of the CrossCover clinical decision support system for musculoskeletal consultations in UK general practice. *Journal of Medical Internet Research*. PubMed. https://pubmed.ncbi.nlm.nih.gov/42879770/

ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.